Quick answer
Brand-name semaglutide products, Ozempic and Wegovy, are FDA approved, meaning the FDA has reviewed their manufacturing, safety, and effectiveness. Compounded semaglutide is made by a compounding pharmacy and is not an FDA-approved product; the FDA does not review compounded drugs for safety, effectiveness, or quality the same way. Compounding became widespread during shortages of the brand products. The two are not equivalent, and the FDA has raised concerns about compounded versions. This guide explains the real difference plainly and non-promotionally so you can ask a prescriber the right questions. These are prescription products requiring physician supervision.
What Is Compounded Semaglutide?
Compounded semaglutide is a version of the drug prepared by a compounding pharmacy rather than manufactured and sold as an FDA-approved product like Ozempic or Wegovy. Compounding is a legitimate pharmacy practice for specific situations, such as when a patient needs a formulation that is not commercially available, and it expanded for semaglutide largely because the brand products were in shortage. When a drug is on the FDA shortage list, certain rules allow compounding that would otherwise be restricted.
The critical point is that compounded does not mean FDA approved. The FDA reviews approved products for manufacturing quality, safety, and effectiveness; it does not review individual compounded preparations in that way. So a compounded product can vary in source, purity, and concentration in ways an approved product does not, which is why oversight by a prescriber and a reputable pharmacy matters.
How Is Compounded Different from Brand-Name Semaglutide?
The core difference is regulatory: brand-name Ozempic and Wegovy went through FDA review for safety, effectiveness, and manufacturing quality, while compounded semaglutide did not. That has practical consequences. Compounded products may differ in concentration and how they are dosed, sometimes supplied in vials drawn up by syringe rather than a fixed-dose pen, which introduces room for dosing error. The FDA has also flagged that some compounded products used salt forms of semaglutide that are not the same active ingredient as the approved drugs.
It is important not to imply that compounded is equivalent to brand simply because it shares a name. It may contain semaglutide, but the assurances that come with FDA approval, consistent manufacturing, verified purity, standardized dosing, do not automatically apply. A prescriber and pharmacy you trust, transparency about the source, and clear dosing instructions are what reduce the added risk.
What Has the FDA Said About Compounded Semaglutide?
The FDA has issued cautions about compounded semaglutide. It has noted that it does not review compounded drugs for safety, effectiveness, or quality, that some compounded products have used salt forms (such as semaglutide sodium or semaglutide acetate) that are not the active ingredient in the approved drugs, and that it has received reports of adverse events including dosing errors, often from patients measuring and self-administering doses from vials. As brand shortages have resolved, the conditions that broadly permitted compounding have changed, which affects when compounding is allowed at all.
This is a moving regulatory picture, so the responsible step is to confirm the current status with a prescriber rather than rely on a marketing claim. The takeaway is not that compounding is inherently illegitimate, it has a real role, but that compounded semaglutide carries different oversight and different risks than the approved products, and anyone offering it should be transparent about that.
What Should You Ask Before Considering Compounded Semaglutide?
Ask whether an FDA-approved option is available to you first, since shortage status affects whether compounding is even appropriate. Ask where the compounded product is sourced, what form of semaglutide it contains, how it is dosed and measured, and what monitoring is in place. Ask the same questions you would about any GLP-1: who supervises treatment, what labs are checked, and how side effects are handled. A trustworthy provider answers these directly and does not claim compounded is identical to brand.
The same screening and supervision that apply to brand-name GLP-1 therapy apply here: eligibility, contraindications, titration, and follow-up. Ascend's medical weight loss program and primary care team can talk through the appropriate, available options for your situation and supervise treatment properly. Decisions about compounded products should be made with a clinician, not from an ad.
Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.
Frequently asked questions
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Ozempic and Wegovy are FDA-approved products with reviewed manufacturing, safety, and effectiveness. Compounded semaglutide is not FDA approved and is not evaluated the same way, and some compounded products have used salt forms that are not the approved active ingredient. They should never be presented as identical.
Is compounded semaglutide legal in Florida?
Compounding is a regulated pharmacy practice, and its legality for a given drug depends on factors like FDA shortage status and the rules governing the compounding pharmacy. Because that status changes, you should confirm the current situation with a licensed prescriber and pharmacy rather than assume. A reputable clinic will be transparent about whether compounding is appropriate and permitted for you.
Why is compounded semaglutide cheaper?
It is often priced lower than brand products, but the lower price reflects that it is not an FDA-approved product and does not carry the same review, standardized manufacturing, and fixed-dose delivery. A lower price is not evidence of equivalence. Weigh cost against the difference in oversight and the FDA's stated concerns, with a prescriber.
Can I get semaglutide by telehealth in Florida without it being compounded?
Often, yes. Florida law allows a licensed clinician to evaluate you and prescribe an FDA-approved semaglutide product by telehealth when appropriate and available. Whether the brand product is accessible can depend on supply and insurance. Ascend evaluates the appropriate, available option case by case rather than defaulting to any one route.
Medically reviewed by
Dr. Jason Saylor, DO
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov.
- U.S. Food and Drug Administration. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. fda.gov.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Prescription Medications to Treat Overweight and Obesity. niddk.nih.gov.